Skip Navigation



Europace Advance Access published online on May 23, 2007

Europace, doi:10.1093/europace/eum101
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
9/7/481    most recent
eum101v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Wang, X.-h.
Right arrow Articles by Hu, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, X.-h.
Right arrow Articles by Hu, W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2007. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Early identification and treatment of PV re-connections: role of observation time and impact on clinical results of atrial fibrillation ablation

Xin-hua Wang, Xu Liu*, Yu-min Sun, Jia-ning Gu, Hai-feng Shi, Li Zhou and Wei Hu

Department of Cardiology, Shanghai Chest Hospital affiliated to Jiaotong University, Shanghai 200030, People's Republic of China

Aims Circumferential pulmonary vein isolation (CPVI) has been reported to account for 30% of atrial fibrillation (AF) recurrence after initial ablation, and pulmonary vein (PV) re-connection accounts for about 80% of AF recurrence. There is no information in the literature whether early identification and treatment of acute PV conduction recovery during initial ablation has an impact on subsequent clinical results. The objective is to investigate the prevalence of acute PV conduction recovery during the observation time after PV isolation for paroxysmal AF, and to evaluate the impact of re-isolation treatment on clinical results.

Methods and results Ninety cases with paroxysmal AF (51 males, mean age of 56.4 ± 12.3 years) were randomized to 3 groups to undergo CPVI. In Group A, there was no observation time post-ablation. In Group B, there was 30 min of observation time post-ablation. In Group C, there was 60 min of observation time post-ablation. All PV re-conduction was re-isolated at the end of the observation time. ECG and Holter monitors were used to evaluate the clinical effectiveness of ablation. All cases underwent the procedure successfully. The mean procedural time in Group A was significantly shorter than in Group B and Group C, but there was no significant difference on fluoroscopic time and PV isolation time among the three groups. In Group B, PV re-conduction occurred in 8 cases (25%) at 30 min post-isolation, in 10 cases (31.2%) at 60 min post-isolation for left PVs, and in 6 cases (18.8%) at 30 min post-isolation for right PVs. In Group C, PV re-conduction for left PVs occurred in 9 cases (30%) at 30 min post-isolation and in 11 cases (36.7%) at 60 min post-isolation; for right PVs this occurred in 7 cases (23.3%) at 30 min post-isolation and in 8 cases (26.7%) at 60 min post-isolation. During a mean follow-up of 6.7 ± 2.3 months, 17 cases (60.7%) in Group A, 27 cases (84.3%) in Group B, and 26 cases (86.7%) in Group C had no recurrence of atrial tachyarrhythmias, P = 0.04.

Conclusion The prevalence of acute PV conduction recovery was about 30% after PV isolation, which mostly occurred within 30 min after initial isolation. Re-isolation of recovered PV conduction contributed to the improvement in the success rate of ablation for paroxysmal AF.

Key Words: Atrial fibrillation, Pulmonary vein, Ablation, Recurrence


* Corresponding author. Tel: 86 21 62821990 60605; fax: 86 21 62821105. E-mail address: xkliuxu{at}126.com

Manuscript submitted 20 February 2007. Accepted after revision 21 April 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
T. Terasawa, E. M. Balk, M. Chung, A. C. Garlitski, A. A. Alsheikh-Ali, J. Lau, and S. Ip
Systematic Review: Comparative Effectiveness of Radiofrequency Catheter Ablation for Atrial Fibrillation
Ann Intern Med, August 4, 2009; 151(3): 191 - 202.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
P. Kirchhof, J. Bax, C. Blomstrom-Lundquist, H. Calkins, A. J. Camm, R. Cappato, F. Cosio, H. Crijns, H.-C. Diener, A. Goette, et al.
Early and comprehensive management of atrial fibrillation: Proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled 'research perspectives in atrial fibrillation'
Europace, July 1, 2009; 11(7): 860 - 885.
[Full Text] [PDF]


Home page
EuropaceHome page
G. B. Chierchia, C. de Asmundis, S.-A. Muller-Burri, A. Sarkozy, L. Capulzini, G. Paparella, S. Chierchia, M. Roos, and P. Brugada
Early recovery of pulmonary vein conduction after cryoballoon ablation for paroxysmal atrial fibrillation: a prospective study
Europace, April 1, 2009; 11(4): 445 - 449.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
X.-H. Wang, X. Liu, Y.-M. Sun, H.-F. Shi, L. Zhou, and J.-N. Gu
Pulmonary vein isolation combined with superior vena cava isolation for atrial fibrillation ablation: a prospective randomized study
Europace, May 1, 2008; 10(5): 600 - 605.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
X.-h. Wang, H.-f. Shi, Y.-m. Sun, J.-n. Gu, L. Zhou, and X. Liu
Circumferential pulmonary vein isolation: the role of key target sites
Europace, February 1, 2008; 10(2): 197 - 204.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.